I originally studied Biomedicine at the University of Hull/ Hull York Medical School with a thesis entitled "Investigating the effects of fibre fermentation on SP family member binding at the P21 promoter site and the implications in colon cancer" I subsequently studied for an MSc in Molecular Medicine (Cardiology) at the University of Sheffield where I developed a novel high-throughput screen to identify drugs which up-regulate the transcription factor klf2a. This is known to protect against the development of cardiovascular disease in humans. I'm currently undertaking a PhD at Liverpool John Moores University within the Research Institute for Sport and Exercise Science and Faculty of Education, Health and Community developing a novel non-invasive method to predict risk in patients undergoing Coronary Artery Bypass Graft Surgery.
2012, University of Hull/ Hull York Medical School, England, BSc Biomedicine
University of Sheffield Medical School, United Kingdom, MSc in Molecular Medicine (Cardiology)